Recombinant Opisthorchis viverrini tetraspanin expressed in Pichia pastoris as a potential vaccine candidate for opisthorchiasis
暂无分享,去创建一个
A. Loukas | P. Brindley | T. Laha | J. Sotillo | Sujittra Chaiyadet | Nuttanan Hongsrichan | L. T. Phung | H. D. T. Dieu | Canh Quang Tran
[1] A. Loukas,et al. Vaccination of hamsters with Opisthorchis viverrini extracellular vesicles and vesicle-derived recombinant tetraspanins induces antibodies that block vesicle uptake by cholangiocytes and reduce parasite burden after challenge infection , 2019, PLoS neglected tropical diseases.
[2] N. Khuntikeo,et al. Current Perspectives on Opisthorchiasis Control and Cholangiocarcinoma Detection in Southeast Asia , 2018, Front. Med..
[3] A. Loukas,et al. Suppression of mRNAs encoding CD63 family tetraspanins from the carcinogenic liver fluke Opisthorchis viverrini results in distinct tegument phenotypes , 2017, Scientific Reports.
[4] A. Haque,et al. IL‐6 promotes CD4+ T‐cell and B‐cell activation during Plasmodium infection , 2017, Parasite immunology.
[5] A. Loukas,et al. Proteomic characterization of the internalization of Opisthorchis viverrini excretory/secretory products in human cells. , 2017, Parasitology international.
[6] N. Khuntikeo,et al. Changing patterns of prevalence in Opisthorchis viverrini sensu lato infection in children and adolescents in northeast Thailand. , 2016, Acta tropica.
[7] G. Wu,et al. Protection and immunological study on two tetraspanin‐derived vaccine candidates against schistosomiasis japonicum , 2016, Parasite immunology.
[8] A. Loukas,et al. Schistosomiasis vaccines: where do we stand? , 2016, Parasites & Vectors.
[9] S. Ponphimai,et al. Raw Fish Consuming Behavior Related to Liver Fluke Infection among Populations at Risk of Cholangiocarcinoma in Nakhon Ratchasima Province, Thailand. , 2016, Asian Pacific journal of cancer prevention : APJCP.
[10] G. Cheng,et al. Molecular characterization of S. japonicum exosome-like vesicles reveals their regulatory roles in parasite-host interactions , 2016, Scientific Reports.
[11] Shuai Jiang,et al. Recent advances in the production of recombinant subunit vaccines in Pichia pastoris , 2016, Bioengineered.
[12] J. Dalton,et al. The Extracellular Vesicles of the Helminth Pathogen, Fasciola hepatica: Biogenesis Pathways and Cargo Molecules Involved in Parasite Pathogenesis , 2015, Molecular & Cellular Proteomics.
[13] A. Loukas,et al. Carcinogenic Liver Fluke Secretes Extracellular Vesicles That Promote Cholangiocytes to Adopt a Tumorigenic Phenotype , 2015, The Journal of infectious diseases.
[14] A. Ivens,et al. Protein and small non-coding RNA-enriched extracellular vesicles are released by the pathogenic blood fluke Schistosoma mansoni , 2015, Journal of extracellular vesicles.
[15] G. Munirathinam,et al. Large Extracellular Loop of Tetraspanin as a Potential Vaccine Candidate for Filariasis , 2013, PloS one.
[16] P. Hotez,et al. Expression at a 20L scale and purification of the extracellular domain of the Schistosoma mansoni TSP-2 recombinant protein , 2013, Human vaccines & immunotherapeutics.
[17] A. Loukas,et al. Molecular Characterization of a Tetraspanin from the Human Liver Fluke, Opisthorchis viverrini , 2012, PLoS neglected tropical diseases.
[18] A. Loukas,et al. The tumorigenic liver fluke Opisthorchis viverrini--multiple pathways to cancer. , 2012, Trends in parasitology.
[19] J. Barta,et al. Protective immunization of hamsters against Opisthorchis viverrini infection is associated with the reduction of TGF-β expression. , 2012, Acta tropica.
[20] A. Loukas,et al. Elevated Plasma IL-6 Associates with Increased Risk of Advanced Fibrosis and Cholangiocarcinoma in Individuals Infected by Opisthorchis viverrini , 2012, PLoS neglected tropical diseases.
[21] S. Liang,et al. The current status of opisthorchiasis and clonorchiasis in the Mekong Basin. , 2012, Parasitology international.
[22] H. Wakaguri,et al. A Pilot Study on Developing Mucosal Vaccine against Alveolar Echinococcosis (AE) Using Recombinant Tetraspanin 3: Vaccine Efficacy and Immunology , 2012, PLoS neglected tropical diseases.
[23] A. Loukas,et al. Enhanced Protective Efficacy of a Chimeric Form of the Schistosomiasis Vaccine Antigen Sm-TSP-2 , 2012, PLoS neglected tropical diseases.
[24] A. Loukas,et al. The secreted and surface proteomes of the adult stage of the carcinogenic human liver fluke Opisthorchis viverrini , 2010, Proteomics.
[25] T. Boonmars,et al. Animal models for Opisthorchis viverrini infection , 2009, Parasitology Research.
[26] G. Ciliberto,et al. The induction of antibody production by IL-6 is indirectly mediated by IL-21 produced by CD4+ T cells , 2009, The Journal of experimental medicine.
[27] M. Neurath,et al. In vitro generation of CD4+CD25+ regulatory cells from murine naive T cells , 2007, Nature Protocols.
[28] A. Loukas,et al. Gene discovery for the carcinogenic human liver fluke, Opisthorchis viverrini , 2007, BMC Genomics.
[29] A. Loukas,et al. Tetraspanins on the surface of Schistosoma mansoni are protective antigens against schistosomiasis , 2006, Nature Medicine.
[30] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[31] Phubet Saengsawang,et al. Reinfection by Opisthorchis Viverrini after Treatment with Praziquantel. , 2016, Asian Pacific journal of cancer prevention : APJCP.
[32] A. Loukas,et al. Immunization and challenge shown by hamsters infected with Opisthorchis viverrini following exposure to gamma-irradiated metacercariae of this carcinogenic liver fluke. , 2016, Journal of helminthology.
[33] A. Loukas,et al. Extracellular vesicles secreted by Schistosoma mansoni contain protein vaccine candidates. , 2016, International journal for parasitology.
[34] S. Tyring,et al. Vaccine immunology , 2009, Dermatologic therapy.
[35] R. Anderson,et al. The epidemiology and control of intestinal helminths in the Pulicat Lake region of Southern India. I. Study design and pre- and post-treatment observations on Ascaris lumbricoides infection. , 1986, Transactions of the Royal Society of Tropical Medicine and Hygiene.